$10.10 0.1%
Price vs. AI Score (Last 150 days)
Data gathered: April 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

Data Bits

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.


Arcutis Biotherapeutics
Price $10.10
Target Price Sign up
Volume 1,860,000
Market Cap $1.17B
Dividend Yield 0%
Revenue per Employee $165,243
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '235.8M58M-52M-66M-58M-0.720
Q3 '2331M236M-205M-45M154M-0.730
Q2 '235.2M234M-229M-71M124M-1.160
Q1 '232.8M43M-47M-80M-73M-1.310
Q4 '223M40M-44M-72M-65M-1.180

Insider Transactions View All

Moore Matthew Richard filed to sell 146,020 shares at $11.1.
March 6 '24
Burnett Patrick filed to sell 269,300 shares at $11.1.
March 6 '24
Matsuda Masaru filed to sell 190,424 shares at $11.1.
March 6 '24
Heron Patrick J filed to buy 8,785,284 shares at $9.5.
March 6 '24
Watanabe Todd Franklin filed to sell 874,533 shares at $11.1.
March 6 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Oct 15, 23 Sell $1K - $15K
Joshua Gottheimer
Democrat
May 19, 23 Buy $1K - $15K
Joshua Gottheimer
Democrat
Jul 22, 22 Buy $1K - $15K

What is the Market Cap of Arcutis Biotherapeutics?

The Market Cap of Arcutis Biotherapeutics is $1.17B.

How Many People Work at Arcutis Biotherapeutics?

As of our latest update, Arcutis Biotherapeutics employed approximately 268 people worldwide. However, it's important to note that Arcutis Biotherapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Arcutis Biotherapeutics' revenue per employee?

$165,243. To calculate Arcutis Biotherapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current price of Arcutis Biotherapeutics?

Currently, the price of one share of Arcutis Biotherapeutics is $10.10.

How can I analyze the ARQT stock price chart for investment decisions?

The ARQT stock price chart above provides a comprehensive visual representation of Arcutis Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arcutis Biotherapeutics shares. Our platform offers an up-to-date ARQT stock price chart, along with technical data analysis and alternative data insights.

Does ARQT offer dividends to its shareholders?

As of our latest update, Arcutis Biotherapeutics (ARQT) does not offer dividends to its shareholders. Investors interested in Arcutis Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Arcutis Biotherapeutics?

Some of the similar stocks of Arcutis Biotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.